1. Home
  2. OVID vs SHLT Comparison

OVID vs SHLT Comparison

Compare OVID & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • SHLT
  • Stock Information
  • Founded
  • OVID 2014
  • SHLT 1987
  • Country
  • OVID United States
  • SHLT Israel
  • Employees
  • OVID N/A
  • SHLT N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • SHLT Business Services
  • Sector
  • OVID Health Care
  • SHLT Consumer Discretionary
  • Exchange
  • OVID Nasdaq
  • SHLT Nasdaq
  • Market Cap
  • OVID 47.1M
  • SHLT 39.3M
  • IPO Year
  • OVID 2017
  • SHLT N/A
  • Fundamental
  • Price
  • OVID $0.45
  • SHLT $2.20
  • Analyst Decision
  • OVID Strong Buy
  • SHLT Strong Buy
  • Analyst Count
  • OVID 6
  • SHLT 1
  • Target Price
  • OVID $3.20
  • SHLT $11.00
  • AVG Volume (30 Days)
  • OVID 312.2K
  • SHLT 4.2K
  • Earning Date
  • OVID 03-11-2025
  • SHLT 04-16-2025
  • Dividend Yield
  • OVID N/A
  • SHLT N/A
  • EPS Growth
  • OVID N/A
  • SHLT N/A
  • EPS
  • OVID N/A
  • SHLT N/A
  • Revenue
  • OVID $566,000.00
  • SHLT $55,939,000.00
  • Revenue This Year
  • OVID N/A
  • SHLT N/A
  • Revenue Next Year
  • OVID N/A
  • SHLT N/A
  • P/E Ratio
  • OVID N/A
  • SHLT N/A
  • Revenue Growth
  • OVID 44.50
  • SHLT N/A
  • 52 Week Low
  • OVID $0.46
  • SHLT $2.03
  • 52 Week High
  • OVID $3.45
  • SHLT $7.96
  • Technical
  • Relative Strength Index (RSI)
  • OVID 30.65
  • SHLT 51.89
  • Support Level
  • OVID $0.50
  • SHLT $2.05
  • Resistance Level
  • OVID $0.58
  • SHLT $2.60
  • Average True Range (ATR)
  • OVID 0.06
  • SHLT 0.17
  • MACD
  • OVID 0.00
  • SHLT 0.03
  • Stochastic Oscillator
  • OVID 13.30
  • SHLT 86.36

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About SHLT SHL Telemedicine Ltd

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.

Share on Social Networks: